This post hoc analysis assessed the HbA1c-lowering efficacy of semaglutide, a GLP-1RA, in participants with a range of kidney functions in the SUSTAIN 46 and 10 (subcutaneous semaglutide) and PIONEER 5 and 6 (oral semaglutide) clinical trials.
Find out if GLP-1 medications will lower your A1C and how they work to improve blood sugar control. Learn about efficacy, dosage, and side effects for diabetes management.
s more patients succeed on GLP-1 therapy, conversations about tapering these medications are becoming increasingly common in metabolic care. When patients reach meaningful goals in weight reduction, A1C improvement, or cardiometabolic risk, clinicians naturally begin asking what comes next. Is it safe to stop treatment?
Such details provide a deeper understanding and appreciation for How To Lower A1C Levels With Glp 1 Therapy.
If your A1C is not improving despite several months on GLP-1 therapy, discuss this with your provider. Possible explanations include needing a higher dose, requiring additional diabetes medications, or needing to reassess lifestyle factors affecting blood sugar.
GLP-1 receptor agonists not only have been associated with lowering A1C levels early and keeping those levels low, but some are also associated with weight loss, reduction of major cardiovascular events, and renoprotective effects through their microvascular benefits (8).
